BDBM130034 US8815926, 316
SMILES: COc1ncc(-c2nc3C(=O)N([C@H](c3n2[C@H](C)CO)c2ccc(Cl)cc2)c2cccc(Cl)c2F)c(OC)n1
InChI Key: InChIKey=ZIVYGCBNCGFBLY-ASSNKEHSSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDM2-MDMX (Homo sapiens (Human)) | BDBM130034 (US8815926, 316) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.107 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfe... | US Patent US8815926 (2014) BindingDB Entry DOI: 10.7270/Q29P309G | |||||||||||
More data for this Ligand-Target Pair |